j uma's Insider Trades & SAST Disclosures

j uma's most recent trade in Shaily Engineering Plastics Ltd. was a Pledge of 3,150 Equity Shares done at an average price of Rs. 2909.1 . Disclosure was reported to the exchange on June 17, 2026 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

j uma's has made SAST transactions in Clinitech Laboratory Ltd. recently where a Acquisition of 8,400 shares done . Disclosure was reported to the exchange on March 12, 2026.

Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Shaily Engineering
JAYESH UMANGLAL SHAH Designated Person Pledge 17 Jun 2026 3,150 7,000 (0.02%) 0.01% 2909.1 9,163,508 16 Jun 2026
16 Jun 2026
Insider Trading Equity Shares Creation Of Pledge
Shaily Engineering
JAYESH UMANGLAL SHAH Designated Person Disposal 02 Jun 2026 650 3,850 (0%) 0.00% 3100 2,015,000 01 Jun 2026
01 Jun 2026
Insider Trading Equity Shares Market Sale
Clinitech Laboratory
Jagdish Umakant Nayak Promoter Acquisition 10 Apr 2026 8,400 705,700 (30.92%) 0.37% - 11 Mar 2026
11 Mar 2026
SAST (29(2)) - Market
Clinitech Laboratory
Jagdish Umakant Nayak & PACs Promoter Acquisition 10 Apr 2026 4,800 1,460,600 (63.99%) 0.21% - 19 Mar 2026
20 Mar 2026
SAST (29(2)) - Market
Clinitech Laboratory
Jagdish Umakant Nayak Promoter Acquisition 10 Apr 2026 3,600 697,300 (30.55%) 0.16% - 10 Mar 2026
10 Mar 2026
SAST (29(2)) - Market
Clinitech Laboratory
Jagdish Umakant Nayak & PACs Promoter Acquisition 10 Apr 2026 4,800 1,455,800 (63.78%) 0.21% - 17 Mar 2026
18 Mar 2026
SAST (29(2)) - Market
Clinitech Laboratory
Jagdish Umakant Nayak Promoter Acquisition 10 Apr 2026 6,000 711,700 (31.18%) 0.26% - 12 Mar 2026
13 Mar 2026
SAST (29(2)) - Market
Clinitech Laboratory
Jagdish Umakant Nayak & PACs Promoter Acquisition 10 Apr 2026 1,200 1,464,200 (64.15%) 0.05% - 25 Mar 2026
25 Mar 2026
SAST (29(2)) - Market
Clinitech Laboratory
Mr. Jagdish Umakant Nayak Promoter & Director Acquisition 30 Mar 2026 9,600 732,100 (32.08%) 0.42% 35 336,000 30 Mar 2026
30 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
Mr. Jagdish Umakant Nayak Promoter & Director Acquisition 27 Mar 2026 1,200 722,500 (31.65%) 0.05% 35 42,000 25 Mar 2026
25 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 20 Mar 2026 4,800 721,300 (31.60%) 0.21% 37.5 180,000 19 Mar 2026
20 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 18 Mar 2026 4,800 716,500 (31.39%) 0.21% 0 0 17 Mar 2026
18 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 13 Mar 2026 6,000 711,700 (31.18%) 0.26% 41.4 248,400 12 Mar 2026
13 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 12 Mar 2026 8,400 705,700 (30.92%) 0.37% 41.4 348,000 11 Mar 2026
11 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 10 Mar 2026 3,600 697,300 (30.55%) 0.16% 42.2 152,064 10 Mar 2026
10 Mar 2026
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
Jagdish Umakant Nayak Promoter Acquisition 17 Oct 2025 8,400 693,700 (30.39%) 0.37% - 26 Sep 2025
26 Sep 2025
SAST (29(2)) - Market
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 27 Sep 2025 8,400 693,700 (30.39%) 0.37% 45.2 379,272 26 Sep 2025
26 Sep 2025
Insider Trading Equity Shares Market Purchase
Clinitech Laboratory
Jagdish Umakant Nayak Promoter Acquisition 18 Sep 2025 8,400 682,900 (29.92%) 0.37% - 18 Aug 2025
18 Aug 2025
SAST (29(2)) - Market
Clinitech Laboratory
JAGDISH UMAKANT NAYAK Promoter & Director Acquisition 20 Aug 2025 8,400 682,900 (29.92%) 0.37% 44 369,600 18 Aug 2025
18 Aug 2025
Insider Trading Equity Shares Market Purchase
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST